Pyxis Oncology Inc
PYXS
Get informed when a big investor buys or sells
+ FollowMarket Cap$204.64M
Close$
$0.38
89.3% downside
Current Fair Value
89.3% downsideOvervalued by 89.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $204.64 Million |
|---|---|
| Enterprise Value | $203.62 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.28 |
| Beta | 1.32 |
| Outstanding Shares | 63,991,609 |
Return
| Return on Equity | -775.59% |
|---|---|
| Return on Assets | -161.55% |
| Return on Invested Capital | -336.04% |
Valuation & Multiples
| P/E Ratio | -2.29 |
|---|---|
| PEG | -6.01 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 18.45 |
| Enterprise Value to EBIT | -2.21 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 1.56 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$-0.35
Average shareholder expectationRevenue Estimate
$21,875
Average shareholder expectationNext Earnings Call
Expected Date
November 2, 2026
EPS Estimate
$-0.27
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 23.10% |
|---|---|
| Total Calls | 134,900▼ 47.26% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 43.44%▼ 5.15% |
|---|---|
| Total Invested | $40.53M▲ 16.69% |
| Investors Holding | 810% |
ESG Score
No data